We are dedicated to developing mRNA genetic treatments for all Duchenne Muscular Dystrophy.

We continue to pursue opportunities to collaborate with companies, academia, patient advocacy groups and other industry stakeholders worldwide. If you are interested in a partnering with Art Bioscience to push forward developments for those impacted by rare and debilitating DMD diseases, please contact us at info@artbioscience.com